On September 5, 2025, TuHURA Biosciences finalized a $3.2 million purchase agreement as part of a larger offering, allowing investors to buy shares and extend warrant expirations to 2030. This follows a broader $12.6 million deal for 4.76 million shares and warrants announced earlier on June 2, 2025.